This randomized clinical trial compares outcomes of standard chemotherapy and cetuximab combination therapy with vs without motolimod in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.
https://ift.tt/2M9KSwp
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
-
http://bit.ly/2SylJiJ
-
Publication date: June 2018 Source: Acta Biomaterialia, Volume 73 https://ift.tt/2kBbISt
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου